Scorpion venom provides clues to cause, treatment of pancreatitis

Mar 29, 2010

A Brazilian scorpion has provided researchers at North Carolina State University and East Carolina University insight into venom's effects on the ability of certain cells to release critical components. The findings may prove useful in understanding diseases like pancreatitis or in targeted drug delivery.

A common result of scorpion stings, pancreatitis is an inflammation of the pancreas. ECU microbiologist Dr. Paul Fletcher believed that scorpion venom might be used as a way to discover how pancreatitis occurs - to see which cellular processes are affected at the onset of the disease. Fletcher pinpointed a production system found in the pancreas that seemed to be targeted by the venom of the Brazilian scorpion Tityus serrulatus and then contacted NC State physicist Dr. Keith Weninger, who had studied that particular protein system.

"This particular protein system has special emphasis at two places in the body - the pancreas and the nervous system," Weninger says. "In the pancreas, it is involved in the release of proteins through the membrane of a cell." The pancreas specializes in releasing two kinds of proteins using separate cells: that go into the and insulin and its relatives that go into the bloodstream, yet this same release mechanism is important in all of our cells for many processes.

Cells move components in and out through a process called vesicle fusion. The vesicle is a tiny, bubble-like chamber inside the cell that contains the substance to be moved, stored and released - in this case, proteins like enzymes or hormones. The vesicle is moved through the cell and attaches to the exterior membrane, where the vesicle acts like an airlock in a spaceship, allowing the cell membrane to open and release the proteins without disturbing the rest of the cell's contents. The proteins that aid in this process are known as Vesicle Associated , or VAMPs.

Weninger provided Fletcher with two different VAMP proteins found in the pancreas, VAMP2 and VAMP8. They were engineered to remove the membrane attachments so they could be more easily used for experiments outside cells and tissues. Fletcher's team demonstrated that the attacked the VAMP proteins, cutting them in one place and eliminating the vesicle's ability to transport its protein cargo out of the cell.

The results were published in the March 5 issue of the Journal of Biological Chemistry.

"We found that a particular enzyme in the scorpion's venom removes a peptide, or small protein, that allows the vesicle to fuse with the cell membrane," Fletcher says. "If you remove a cell's ability to absorb or release components, you end up with pancreatitis."

"Viruses often exploit the same mechanism of vesicle fusion, but in reverse, in order to invade cells and replicate," Weninger adds. "This work furthers our understanding of a basic and may lead to treatments for viruses and advances in treatments like chemotherapy, by allowing targeted drug delivery only to cancer cells."

Explore further: Scientists make diseased cells synthesize their own drug

More information: "Vesicle-associated Membrane Protein (VAMP) Cleavage by a New Metalloprotease from the Brazilian Scorpion Tityus serrulatus", Paul L. Fletcher, et al., March 5, 2010, in Journal of Biological Chemistry; VOL. 285, NO. 10, pp. 7405.

Related Stories

Researchers uncover secrets of salmonella's stealth attack

Apr 16, 2009

A single crafty protein allows the deadly bacterium Salmonella enterica to both invade cells lining the intestine and hijack cellular functions to avoid destruction, Yale researchers report in the April 17 issue of the jo ...

New insight in nerve cell communication

Dec 22, 2009

Communication between nerve cells is vital for our bodies to function. Part of this communication happens through vesicles containing signalling molecules called neurotransmitters. The vesicle fuses with the ...

Recommended for you

Scientists make diseased cells synthesize their own drug

14 hours ago

In a new study that could ultimately lead to many new medicines, scientists from the Florida campus of The Scripps Research Institute (TSRI) have adapted a chemical approach to turn diseased cells into unique manufacturing ...

A new synthetic amino acid for an emerging class of drugs

Aug 31, 2014

Swiss scientists have developed a new amino acid that can be used to modify the 3-D structure of therapeutic peptides. Insertion of the amino acid into bioactive peptides enhanced their binding affinity up to 40-fold. Peptides ...

User comments : 0